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A number of epidemiological studies have attempted to assess the effect of recurrent ozone exposure in humans. For the most part, they have
failed to document convincingly an association between chronic ozone exposure and differences in lung function performance or respiratory symp-
toms. This is not surprising given the small respiratory effects observed in animals chronically exposed to ozone and assuming that people with
abnormal respiratory function resulting from other occupational or environmental exposures, such as tobacco smoke, would make up a much larger
percentage of the population than people with respiratory effects attributable to ozone. Therefore, either more sensitive end points must be devel-
oped to detect subtle changes due to chronic ozone exposure, or ways of selecting subpopulations that are especially sensitive to ozone must be
devised. It has been well documented that there are large and reproducible differences in the acute response of individuals to ozone as measured
by pulmonary function tests. Recently, it has also been shown that there are large differences in the acute response of individuals to ozone as mea-
sured by inflammatory and other biochemical parameters. This paper discusses the problems of selecting individuals who are sensitive to ozone
depending on the end point chosen. It also describes potential new sensitive end points that might be available for ozone epidemiology studies in
the nearfuture. - Environ Health Perspect 101(Suppl 4):225-230 (1993).
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Introduction
It is widelyaccepted that humans exposed to
known concentrations of ozone under con-
trolled conditions exhibit reversible changes
that affect the large and small airways as well
as the alveolar region of the lung. These
changes include reduction in pulmonary
function performance, narrowing of small
airways, increased nonspecific airway reactiv-
ity, alveolar inflammation, damage to pul-
monary epithelial cells, and increased
leakage of vascular components into the
lung. In addition, acute reduction of pul-
monary function performance following
ozone exposure has been documented in epi-
demiological studies in which small groups
were followed over a short period (1-6).
This manuscrpt was prepared as part of the Environ-
mental Epidemiology Planning Project of the Health
Effects Institute, September 1990-September 1992.
*Address correspondence to R. B. Devlin, Medical
Research Building B, University of North Carolina at
Chapel Hill, Chapel Hill, NC 27599.
The research described in this article has been
reviewed by the Health Effects Research Laboratory
of the EPA and approved for publication. Approval
does not signify that the contents necessarily reflect
the views and policies of the Agency, nor does men-
tion of trade names or commercial products constitute
endorsement orrecommendation for use.
However, it is not known if recurrent
exposure to ozone results in induction of
chronic disease. Some studies of chronic
animal exposure suggested that rats and
nonhuman primates exposed to levels of
ozone below 0.5 ppm for up to 2 years
exhibit permanent or slowly reversible
lesions in the distal airway and proximal
alveolar region of the lung. An ongoing
low-level inflammatory process with increased
numbers ofneutrophils was accompanied by
increased numbers of type II alveolar cells,
thickening ofthe basement membrane, and
increased numbers ofcollagen fibers in the
interstitium (7-9). Measurement of pul-
monary function in these animals suggested
verysmall changes in somevariables, includ-
ing total lung capacity and the diffusing
capacity ofcarbon monoxide(10,11).
A number of epidemiological studies
have attempted to assess the effect ofrecur-
rent ozone exposure in humans; they are
summarized by Ostro in this volume. By
and large, these studies havefailed to docu-
ment convincingly an association between
chronic ozone exposure and differences in
lung function performance or respiratory
symptoms. In a discussion ofwhy chronic
effects have not been observed, McDonnell
(12) noted that it is not surprising that
epidemiologists have experienced difficulty
in observing respiratory effects due to
chronic ozone exposure, given that small
respiratory function changes could be
found only in chronically exposed animals
that had developed advanced cellular and
biochemical lesions. If similar lesions
occur in humans, and only a small propor-
tion of individuals with lesions go on to
develop frank disease, it would be difficult
to identify such individuals in an unse-
lected population, particularly given the
rate offrank disease and abnormal respira-
tory function resulting from other occupa-
tional or environmental exposures. Thus,
it would seem that either more sensitive
end points must be developed to detect
chronic effects, or ways of selecting sub-
populations that are sensitive to ozone
must be devised.
There is some evidence that individuals
sensitive to ozone can be identified. As
mentioned above, acute decrements in
forced expiratory volume in 1 sec (FEVI)
have been reported to occur in a concentra-
tion-dependent manner in both controlled
exposure studies and some field studies. In
these studies, the magnitude ofresponse to
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similar concentrations of ozone varies con-
siderably among individuals. For example,
decrements in FEV1 that range from 2 to
48% have been reported in subjects exposed
to levels of ozone between 0 and 0.4 ppm
(13-16). The variation in magnitude of
response is also reproducible when individ-
uals are reexposed to the same level of
ozone up to 13 months later (17,18).
These findings suggest that differences in
individual response to ozone are not due to
random experimental error nor to different
environmental conditions between expo-
sures, but rather to factors that are inherent
in individuals and that are stable over time.
Ifthis suggestion is true, it may be possible
to screen large numbers of individuals in a
controlled setting and to select those with
the largest decrements in pulmonary func-
tion for inclusion in epidemiological studies
ofchronic health effects.
To identify a sensitive subpopulation,
however, one must define the criteria used
to select the population. This is not neces-
sarily straightforward, since there are a
number of parameters that have been
shown to be altered in humans exposed to
ozone. In addition to changes in lung
function tests that primarily measure
inability to take a deep breath (e.g., FVC),
changes in airway constrictions, demon-
strated by an increase in specific airway
resistance (SRaw), have been reported in
animals and humans exposed to ozone.
Increases in nonspecific airway reactivity
have also been observed in humans exposed
to levels of ozone as low as 0.08 ppm
(19,20). Bronchoalveolar lavage (BAL) has
been used to sample both cells and fluid
removed primarily from the alveolar region
ofthe lung ofhumans and animals exposed
to ozone. An influx ofneutrophils; increased
permeability; decreased macrophage phago-
cytic ability; and increases in arachidonic
acid metabolites, some cytokines, fibro-
nectin, lactate dehydrogenase (LDH),
coagulation factors, elastase, and plasmino-
gen activator have been reported in
humans exposed to levels ofozoneas low as
0.08 ppm (21-24). As is the case in pul-
monary function tests, there is a wide range
of individual responses to ozone as mea-
sured by these assays, particularly to low
levels ofozone (21-23). It is not known if
the magnitude of change in these cellular
and biochemical end points is reproducible
over time for a given individual, as is the
case with more traditional markers oflung
function, such as FEV1.
Preliminary analysis ofsome ofthe end
points listed above suggests that none of
them is strongly correlated with another;
individuals who show large decrements in
FEV1 following ozone exposure do not
necessarily have the largest neutrophil
influx or the most nonspecific airway reac-
tivity. Furthermore, drugs that block for-
mation of cyclooxygenase products appear
to ablate partially the pulmonary function
decrements seen after human exposure to
ozone (25,26), but they do not appear to
affect neutrophil (PMN) influx, cell dam-
age, leukotriene production, or increased
permeability reported in humans exposed
to ozone (27). Moreover, there does not
appear to be a strong correlation between
the cellular and biochemical assays when
they are compared with each another. For
instance, rats depleted of PMNs still show
lung damage, production of inflammatory
cytokines, and increased permeability of
vascular components across the epithelial
barrier after ozone exposure (28). Airway
hyperresponsiveness may also occur prior
to and in the absence ofPMN influx in rats
(29) and guinea pigs (30,31). More basic
research into the underlying mechanism of
ozone damage probably will be needed to
understand fully the apparent lack of
coherence ofdifferent end points.
The above discussion does not desig-
nate which end point(s) should be used to
select sensitive individuals. Traditionally,
lung function measurements derived from
forced expiratory maneuvers have been
used to define such people, probably
because these tests are noninvasive, inex-
pensive, and performable on large numbers
of individuals in the field. However, it
might be that end points that measure air-
way hyperreactivity, inflammation, produc-
tion of fibrogenic compounds, or some
combination of these may be better suited
for the selection ofindividuals who may be
at high (or higher than average) risk for
developing frank disease from chronic
ozone exposure.
Additional studies are needed to define
more precisely both the range and repro-
ducibility (over the long and short term) of
individual responses measured bythevarious
endpointsdiscussedabove. Such studieswill
need to combine a number ofend points,
including symptoms (e.g., cough, minor res-
piratory irritation), pulmonary function
changes that reflect lavage and small airway
function, and assays that measure cellular
changes involved in inflammation and lung
damage. Ozone concentration-response
curves for each end pointwill also be needed
to determine ifdifferent doses ofozone alter
the response profile. In addition to defining
therangeandreproducingtheresponse, itwiU
be necessary to determine which, ifany, of
these end points are concordant (i.e. which
ones are consistently elevated in responders
but not in nonresponders). Ifboth invasive
and noninvasive concordant end points are
identified, it will be important to know if
noninvasivemeasuressuch assymptoms, stan-
dard lung function measurements, or mea-
surements ofairwayresistance can be used as
surrogates for more invasive procedures that
measure inflammation, lung injury, reduced
levels ofantioxidants, or reduction in host
defense capability. Ifconcordant end points
are not found, the relevance ofpulmonary
function changes to chronicoutcomes should
be more fully explored before using this end
point to select responders for longitudinal
epidemiology studies.
Under the assumption that suitable end
points are identified, a combination oftwo
approaches would be most useful for the
identification ofsubpopulations sensitive to
ozone. One approach would be to select
subjects for an epidemiological study on
the basis oftheir response to ozone in con-
trolled chamber studies. This would allow
the selection ofindividuals who respond to
precisely known ozone concentrations and
exposure regimens that could mimic those
found in the geographical area in which the
individual resides. One could also be cer-
tain that selected individuals truly are
responsive to ozone rather than other occu-
pational or environmental agents. The
alternative approach would be to select
responders from a cross-sectional study and
attempt to duplicate their response in a
controlled environment. A combination of
both approaches would allow a better
understanding of the relative contribution
ofozone and other environmental agents to
individual range ofresponse.
One problem faced by epidemiologists
attempting to carry out these studies is the
selection of suitable end points. Tradi-
tionally, lung function assays have been
used to assess pulmonary changes in hu-
mans exposed to ozone. This approach is
suitable for detecting acute changes, but it
is not likely to detect minute changes in
small airways that have been demonstrated
in animals chronically exposed to ozone. It
is possible to monitor changes in inflamma-
tory or fibrogenic compounds in the lungs
ofhumans exposed to ozone with biochem-
ical and molecular assays by using BAL to
obtain cells and fluid lining the airways and
alveolar region of the lung. However, the
procedure is relatively invasive and probably
not applicable for studies involving more
than several dozen people. Techniques that
measure changes in the lung not currendy
detected by standard lung function assays,
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yet applicable to large-scale epidemiology
studies are required. Summarized below are
four promising approaches that are cur-
rently being developed in laboratories for
potential use in epidemiology studies.
Tests that Measure Changes
in Small Airways
There is much evidence that humans
exposed to ozone develop reversible decre-
ments in FEV1 and FVC, which have been
attributed to a reduction in total lung
capacity (TLC) that is mediated by neural
mechanisms. There also are obstructive
changes in the large airways that are charac-
terized by small increases in specific airways
resistance (SRaw) and airways reactivity
(32-35). These measurements, however,
do not provide convincing evidence of
functional changes in the small airways of
the lung. Yet, studies of animals acutely
and chronically exposed to ozone show that
tissue damage occurs first in the small air-
ways, particularly in the bronchoalveolar
duct region (36-38). It is likely that ozone
perturbation of this region also would be
reflected by measures that detect functional
change in the airways. To detect small air-
ways functional changes, tests are needed
that do not rely on vital capacity maneu-
vers. This is because any acute small air-
ways change from ozone that might be
detectable from forced expiratory flows at
lowlungvolumes will probably be obscured
bythe reduction in FVC.
Several potential tests of small airway
function have been described. One such
test involves the measurement ofthe disper-
sion of an inhaled bolus of a small (0.5-1
mm) aerosol. This assay has been used to
demonstrate differences between a group of
healthy, nonsmoking individuals and a
group of asymptomatic smokers with oth-
erwise normal lung function; it suggests the
presence of small airways abnormalities in
the latter group (39). Healthy, nonsmok-
ing volunteers exposed to 0.4 ppm ozone
also show differences in the dispersion of
an aerosol bolus, which suggests that ozone
exposure results in functional changes in
the small airways (40). This bolus tech-
nique is relatively noninvasive, easy to per-
form, and can be done on large numbers of
people. It has the potential to measure
functional changes in the region of the
lung known to be most sensitive to ozone
inhalation, which may allow for detection
of changes too small to be detected with
traditional functional measurements
derived from forced expiratory maneuvers.
However, there needs to be more research
comparing the aerosol bolus dispersion
measurement with other putative small air-
ways tests, such as multiple-breath nitrogen
washout or radioactive gas boli, and exam-
ining functional tests ofthe large and small
airways derived from forced expiratory
maneuvers. Experiments also need to be
designed to understand better the underly-
ing structural and functional changes in the
lung that can induce dispersive processes.
Finally, the sensitivity and specificity of
this test needs to be assessed in relation to
other small airways tests.
Tests that Measure Changes
in Nasal Passages
The nose is the primary portal ofentry for
inspired air in humans, and therefore it is
the first region ofthe respiratory tract that is
in contact with airborne pollutants such as
ozone. If these pollutants are respiratory
irritants capable ofcausing cellular damage,
as ozone is, then effects should be detected
in the nasal passages. Since many ofthe cell
types found in the nasopharyngeal region
are the same or similar to cells found in the
trachea and bronchi, the responses of nasal
cells to ozone maybe similar to the response
ofairways and alveolar cells.
Nasal lavage (NL) is simple and eco-
nomical to perform, relatively noninvasive,
and allows multiple sequential sampling of
both nasal secretions and cells from the
same person. This procedure has been
used to study nasal inflammation (as deter-
mined by an influx of PMNs) in humans
exposed to rhinovirus (41) as well as to
study mediators produced in human nasal
fluid during allergic reactions (42). It has
also been used to study changes in the cells
and nasal fluid of humans exposed to
tobacco smoke (43) and workers exposed
to cotton dust (44). In a recent study, an
increase in PMNs has been demonstrated
in the NL fluid of humans exposed to
volatile organic compounds (VOCs) in
equivalent concentrations to those present
in a new house (45). These studies clearly
show the utility ofusing this technique in a
variety ofsettings.
Work with animals has demonstrated
that ozone causes damage to the epithelial
cells of the nasal passages and ultimately
results in an influx of PMNs (46). Two
studies with humans have shown that an
acute exposure to 0.5 or 0.4 ppm ozone
results in a large increase in PMNs in the
NL fluid (47), as well as increased levels of
albumin and tryptase (a marker ofmast cell
degranulation). In the latter study, BAL
was performed on the same individuals,
and a qualitative correlation was found
between the numbers of PMNs in the NL
fluid and in the BAL fluid (48). Thus,
there is a possibility that the noninvasive
NL procedure can be used as a surrogate
for the more costly and invasive BAL in
epidemiological studies with some assur-
ance that inflammation seen in the nasal
passages is mirroring inflammation present
in the alveolar region ofthe lung.
More work is needed to strengthen this
assertion, particularlywhen considering low
ozone concentrations. It is not known if
NL is as sensitive as BAL in the detection of
inflammation or production ofother medi-
ators. Work is also needed to extend the
range of mediators that can be detected in
the NL and to determine if a correlation
exists between BAL and NL for them. This
would include arachidonic acid metabolites,
cytokines, and measurements of cell injury
such as LDH, fibronectin, etc.
In addition to measuring NL fluid for
the presence ofmediators, it is also possible
to perform nasal brush scrapings in which
several thousand cells are removed. These
cells can be analyzed by recently developed
techniques such as RNA in situ hybridiza-
tion and polymerase chain reaction (PCR),
which are capable of analyzing mRNAs
present in only a few hundred cells.
Recently mRNAs coding for cytokines and
other relevant mediators has been quanti-
fied in human upper airway cells removed
by brush scraping (49,50). This approach
may extend both the sensitivity and the
range of end points that can be assayed.
Clearly this newly emerging area needs
more developmental work to validate the
verypreliminary results described to date.
Noninvasive Methods of
Imaging the Lung
The 1973 discovery that nuclear magnetic
resonance (NMR) signals could be spatially
encoded through the use ofmagnetic gradi-
ents has spawned an entire field ofresearch
and application in magnetic resonance
imaging (MRI). A subject is placed in a
strong magnetic field that causes hydrogen
protons to align synchronously about the
direction of the applied field. Radio fre-
quency pulses are then applied to stimulate
the protons and to generate a radio fre-
quencyecho in the tissue. This signal is spa-
tially encoded, which permits the
construction ofa two-dimensional image of
the selected plane through the subject.
Contrast is achieved bychanges in the num-
ber of protons per cubic centimeter, the
spin-lattice relaxation time, and the
spin-spin relaxation time. These parameters
reflect how much water is present in a tissue
andhowthewater is bound to various other
Environmental Health Perspectives Supplements
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molecules. The technique is completely
noninvasive, involves no ionizing radiation,
and can be performed repeatedly on the
same individual over time. MRI has been
used as a diagnostic tool for only the past 6
years, and its current applications include
detection ofpathologic changes in a num-
ber of soft tissues, including hepatitis and
fatty liver, that are associated with chronic
liver disease, infarction of skeletal muscle,
renal lesions, soft tissue tumors, and joint
lesions (51-55).
Recently a number of researchers have
exploited the potential of this tool to
develop MR microscopy, in which sections
through soft tissues can be viewed at <50
mm resolution to permit noninvasive
microscopy on live animals (56-59). This
approach has been used to quantify edema
and fibrosis in the lungs ofanimals exposed
to paraquat (60), as well as edema in ani-
mals exposed to hyperoxia and ozone U.
Crapo, personal communication). This
technique has the potential to become a
powerful tool with the ability to detect
noninvasively ozone-induced lesions in
humans. MRI microscopy can focus on
the whole lung or on a small portion such
as the bronchoalveolar duct region, where
ozone-induced lesions are first visualized by
conventional microscopy.
A number ofproblems must be solved
before MRI microscopy is ready to apply to
humans in an epidemiological study.
Resolution is partly dependent on the size
of the magnet though which the subject
must pass, and current magnets that are
large enough to accommodate humans
yield a resolution ofonly a few millimeters.
It is particularly difficult to create an image
of the normal lung because it has fewer
protons than other tissues, and the micro-
scopic structure ofthe air/water interface in
the alveoli produces distortions resulting in
very long scan times. In addition, distor-
tion due to breathing can reduce resolu-
tion. Fortunately, research in this field is
progressing very rapidly. In the past several
months many of the problems associated
with imaging the lung have been solved,
and now images have greatly increased res-
olution and decreased scanning time. Ifthe
progress in magnet technology continues at
the same pace it has had the past few years,
it can be anticipated that magnets suitable
for visualizing the human lung with high
resolution will be available sometime in
this decade. Developments are currently
underway in which three-dimensional
reconstruction of the lung will allow any
plane to be viewed from any angle without
loss ofresolution.
It is tempting to overstate the impor-
tance MRI microscopy because of its
potential to provide the epidemiologist
with a powerful tool that can visualize the
interior ofa human lung with microscopic
resolution. Clearly there is a considerable
amount of developmental research which
must be done, much of it with animals,
before this technique can be applied to epi-
demiology studies. However, most of the
current developmental effort is focused on
disease models, and research funds must be
provided to encourage development of
models appropriate to environmental epi-
demiology studies. There are at least two
general areas of research that should be
encouraged in the near future. The tech-
nology necessary to measure inflammation
and edema and to visualize lesions in ani-
mals chronically exposed to ozone exists.
Studies are needed in which MRI imaging,
conventional quantitative histology, and
BAL(which can measure inflammation and
lung damage from a cellular and biochemi-
cal perspective) are all applied to animals
exposed to ozone for varying periods of
time. This would allow an assessment of
the ability ofa noninvasive technique such
as MR microscopy to detect acute and
chronic changes in the lung that have
already been described using histology and
BAL. Studies are also needed to assess the
ability of MR microscopy to detect edema
and inflammation in the lung of humans
exposed acutely to ozone. Even if current
MR technology does not permit visualiza-
tion of small structures in humans, MR is
capable ofdetecting more pervasive changes
such as inflammation and edema. These
studies would allow an assessment of
whether MRI could be used as a surrogate
for BAL in epidemiology studies.
Development of Biomarkers
of Exposure and Predictive
Biomarkers
An important quality for any epidemiologi-
cal study would be the ability to perform a
simple test that could quantify the exposure
of an individual to a pollutant or perhaps
even detect individuals who are susceptible
to exposure to a specific pollutant . The
molecular technology necessary to identify
specific macromolecules that could serve as
dosimeters ofexposure to specific pollutants
or to identify components that could serve
as predictive biomarkers ofsensitivity exists
today. Furthermore, the technology needed
when analyzing changes in a tiny number
ofcells (100-1000), which gready expands
the range and type of tissues that poten-
tially can be sampled in an epidemiology
study, also exists. Nearly all of the develop-
mental work and most ofthe current appli-
cations are focused on the identification and
quantification of biomarkers related to dis-
ease. Very little effort has been made to
develop or apply this technology to problems
related to exposure of humans to environ-
mental pollutants. Those operating the labo-
ratories most suited to the development of
the kinds ofbiomarkers needed for epidemi-
ology studies are usually not aware of nor
appreciative ofthe utilityorvalue ofdevelop-
ing these kinds of biomarkers. In addition,
very little funding has been provided by the
epidemiology community for long-term
research dedicated to developing suitable
biomarkers. However, if such biomarkers
are ever to be developed, funding must be
provided and lines ofcommunication must
be opened between epidemiologists and
molecular biologists.
Research, preferably in easily accessible
tissue such as nasal epithelium or blood, is
needed to define the range of proteins and
mRNAs that are induced by exposure of
humans to ozone and other pollutants. It is
likely that different sets of macromolecules
are induced by different pollutants, similar
to the induction of different rat liver pro-
teins by different toxicants (61). If such
sets ofproteins or mRNAs are found in ani-
mals or humans exposed to ozone, studies
will be needed to determine ifa quantitative
relationship exists between induction ofany
protein or mRNA and the level of ozone
exposure. ELISA or RIA assays could then
be developed to quantify specific proteins
(and PCR to quantify specific mRNAs)
whose level of induction is dependent on
the concentration ofozone exposure. This
would allow these macromolecules to serve
as molecular dosimeters ofozone exposure.
If suitable criteria for sensitivity can be
determined, similar approaches can be used
to identify proteins or mRNAs present in
humans judged sensitive to ozone. It is
likely to take at least several years to develop
and validate biomarkers suitable for epi-
demiological studies ofozone, and the diffi-
culties and pitfalls in attempting to identify
such markers have been well documented
by Hatch and Thomas (62). However, the
potential power and utility of these bio-
markers suggest that research in this area
should be pursued. G
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